speb/financial-data huggingface dataset:
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 112700000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 112700000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 40760870.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 5.52
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 225000000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — EBIT: 309900000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — EBITDA: 422600000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 590500000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 15700000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 15700000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Net Income: 225000000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 225000000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 225000000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 225000000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 225000000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 225000000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -15700000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -15700000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 462100000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 255209041.47
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Operating Income: 205200000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2288700000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 144200000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 272600000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 294200000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1698200000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 112700000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -39500000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -9290958.53
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 69200000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.24
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 2083500000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -39500000.00
PROTEAN.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -39500000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — +Operating Expense: 1662800000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 669200000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — +Total Revenue: 9977500000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 3075400000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1361300000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1361300000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2046400000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2046400000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 6103400000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 6103400000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 40560748.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 7.49
PROTEAN.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 378500000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -667800000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: 0.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 874900000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 874900000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 406200000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 406200000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 480800000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 480800000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 3258600000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 3258600000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -405200000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -653700000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 416300000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Change In Payable: 328300000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -616600000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -525700000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 102300000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Common Stock: 406200000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 406200000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 10773500000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 10773500000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 27300000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 17700000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 17700000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 7569400000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2166900000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Current Assets: 6096900000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 6096900000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 178000000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 178000000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 178000000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 178000000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 3054300000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3054300000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 127100000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 127100000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Depreciation: 467500000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 467500000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 467500000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 140600000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 467500000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 140600000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 40723861.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 7.46
PROTEAN.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1005900000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 303800000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — EBIT: 1369200000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — EBIT: 384900000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — EBITDA: 1836700000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — EBITDA: 525500000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — End Cash Position: 480800000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -538700000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 116900000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -89600000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 412500000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 412500000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 1449700000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1449700000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Gross Profit: 2408100000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 908500000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Interest Expense: 66800000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 20800000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 66800000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 20800000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -66800000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 555200000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 10773500000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 10773500000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -143700000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 6103400000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 6103400000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 27300000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 696900000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 696900000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 696900000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 696900000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 211200000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 211200000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 0.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 0.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Minority Interests: 0.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 27300000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Net Income: 1005900000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Net Income: 303800000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1005900000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 303800000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1005900000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 303800000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1005900000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 303800000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1005900000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 303800000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1302400000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1005900000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 303800000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -250300000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Net Interest Income: -66800000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -20800000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -31100000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -66800000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -20800000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Net PPE: 1449700000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 1449700000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -417500000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 10361000000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 10361000000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 216200000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 216200000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1883700000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 533000000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Normalized Income: 1042200138.21
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 310057896.18
PROTEAN.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 784700000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Operating Income: 745300000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Operating Income: 239300000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Operating Revenue: 9977500000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 3075400000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 40616731.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 40616731.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 791900000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 791900000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 922500000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 922500000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 10367300000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 10367300000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 412500000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 412500000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -498100000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 194500000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 194500000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 670900000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 153100000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1195300000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 528600000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Other Properties: 1432000000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 1432000000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 2777800000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 2777800000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Payables: 1425400000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Payables: 1425400000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Pretax Income: 1302400000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 364100000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 118900000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -250300000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -7326600000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -417500000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 7569400000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2166900000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 467500000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 140600000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 7295500000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Share Issued: 40616731.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 40616731.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Special Income Charges: -47000000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -7500000.00
PROTEAN.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 118800000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 10773500000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 10773500000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 10361000000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 10361000000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -10699861.79
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -1242103.82
PROTEAN.NS income_statement (annual, 2026-03-31) — Tax Provision: 296500000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 60300000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.23
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.17
PROTEAN.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -165200000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Total Assets: 14735900000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 14735900000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 10773500000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 10773500000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Total Debt: 874900000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 874900000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 10773500000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 10773500000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Total Expenses: 9232200000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 2836100000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 3962400000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3962400000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 8639000000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 8639000000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 908100000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 908100000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 64100000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 64100000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -47000000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -7500000.00
PROTEAN.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -47000000.00
PROTEAN.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -7500000.00
PROTEAN.NS balance_sheet (annual, 2026-03-31) — Working Capital: 3042600000.00
PROTEAN.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 3042600000.00
PROV balance_sheet (annual, 2021-06-30) — Accounts Payable: 17360000.00
PROV income_statement (annual, 2021-06-30) — Basic Average Shares: 7464814.00
PROV income_statement (annual, 2021-06-30) — Basic EPS: 1.01
PROV income_statement (annual, 2021-06-30) — Diluted Average Shares: 7538409.00
PROV income_statement (annual, 2021-06-30) — Diluted EPS: 1.00
PROV cash_flow (annual, 2021-06-30) — Net Other Financing Charges: -877000.00
PROV cash_flow (annual, 2021-06-30) — Net Other Investing Changes: -185000.00
PROV balance_sheet (annual, 2021-06-30) — Payables: 17360000.00
PROV balance_sheet (annual, 2021-06-30) — Payables And Accrued Expenses: 17360000.00
PROV balance_sheet (annual, 2021-06-30) — Prepaid Assets: 14942000.00
PROV cash_flow (annual, 2021-06-30) — Proceeds From Stock Option Exercised: 981000.00
PROV cash_flow (annual, 2021-06-30) — Sale Of PPE: 0.00
PROV income_statement (annual, 2022-06-30) — +Total Revenue: 36311000.00
PROV balance_sheet (annual, 2022-06-30) — Accounts Payable: 17884000.00
PROV balance_sheet (annual, 2022-06-30) — Accounts Receivable: 2966000.00
PROV balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -14482000.00
PROV balance_sheet (annual, 2022-06-30) — Additional Paid In Capital: 98826000.00
PROV income_statement (annual, 2022-06-30) — Basic Average Shares: 7404089.00
PROV income_statement (annual, 2022-06-30) — Basic EPS: 1.23
PROV cash_flow (annual, 2022-06-30) — Beginning Cash Position: 70270000.00
PROV balance_sheet (annual, 2022-06-30) — Buildings And Improvements: 9896000.00
PROV cash_flow (annual, 2022-06-30) — Capital Expenditure: -165000.00
PROV balance_sheet (annual, 2022-06-30) — Capital Stock: 183000.00
PROV balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 23414000.00
PROV balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Federal Funds Sold: 23414000.00
PROV cash_flow (annual, 2022-06-30) — Cash Dividends Paid: -4146000.00
PROV cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: -6903000.00
PROV cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -51746000.00
PROV cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Operating Activities: 11793000.00
PROV cash_flow (annual, 2022-06-30) — Change In Account Payable: 484000.00
PROV cash_flow (annual, 2022-06-30) — Change In Payable: 484000.00
PROV cash_flow (annual, 2022-06-30) — Change In Payables And Accrued Expense: 484000.00
PROV cash_flow (annual, 2022-06-30) — Change In Prepaid Assets: -2109000.00
PROV cash_flow (annual, 2022-06-30) — Change In Working Capital: -1625000.00
PROV cash_flow (annual, 2022-06-30) — Changes In Cash: -46856000.00
PROV balance_sheet (annual, 2022-06-30) — Common Stock: 183000.00
PROV cash_flow (annual, 2022-06-30) — Common Stock Dividend Paid: -4146000.00
PROV balance_sheet (annual, 2022-06-30) — Common Stock Equity: 128650000.00
PROV cash_flow (annual, 2022-06-30) — Common Stock Payments: -4305000.00
PROV cash_flow (annual, 2022-06-30) — Deferred Income Tax: 1140000.00
PROV cash_flow (annual, 2022-06-30) — Deferred Tax: 1140000.00
PROV cash_flow (annual, 2022-06-30) — Depreciation Amortization Depletion: 4849000.00
PROV cash_flow (annual, 2022-06-30) — Depreciation And Amortization: 4849000.00
PROV income_statement (annual, 2022-06-30) — Diluted Average Shares: 7449004.00
PROV income_statement (annual, 2022-06-30) — Diluted EPS: 1.22
PROV income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: 9093000.00
PROV cash_flow (annual, 2022-06-30) — End Cash Position: 23414000.00
PROV cash_flow (annual, 2022-06-30) — Financing Cash Flow: -6903000.00
PROV cash_flow (annual, 2022-06-30) — Free Cash Flow: 11628000.00
PROV balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 2000.00
PROV income_statement (annual, 2022-06-30) — General And Administrative Expense: 16376000.00
PROV balance_sheet (annual, 2022-06-30) — Gross PPE: 23308000.00
PROV balance_sheet (annual, 2022-06-30) — Held To Maturity Securities: 185745000.00
PROV cash_flow (annual, 2022-06-30) — Income Tax Paid Supplemental Data: 2725000.00
PROV income_statement (annual, 2022-06-30) — Insurance And Claims: 543000.00
PROV income_statement (annual, 2022-06-30) — Interest Expense: 3135000.00
PROV income_statement (annual, 2022-06-30) — Interest Income: 34730000.00
PROV cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 3171000.00
PROV balance_sheet (annual, 2022-06-30) — Invested Capital: 213650000.00
PROV cash_flow (annual, 2022-06-30) — Investing Cash Flow: -51746000.00
PROV balance_sheet (annual, 2022-06-30) — Investments And Advances: 188421000.00
PROV cash_flow (annual, 2022-06-30) — Issuance Of Debt: 5000000.00
PROV balance_sheet (annual, 2022-06-30) — Land And Improvements: 2853000.00
PROV balance_sheet (annual, 2022-06-30) — Leases: 2996000.00
PROV balance_sheet (annual, 2022-06-30) — Long Term Debt: 85000000.00
PROV balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 85000000.00
PROV cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 0.00
PROV cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -20983000.00
PROV balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 5427000.00
PROV cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: -4305000.00
PROV balance_sheet (annual, 2022-06-30) — Net Debt: 61586000.00
PROV income_statement (annual, 2022-06-30) — Net Income: 9093000.00
PROV income_statement (annual, 2022-06-30) — Net Income Common Stockholders: 9093000.00
PROV income_statement (annual, 2022-06-30) — Net Income Continuous Operations: 9093000.00
PROV income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: 9093000.00
PROV income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: 9093000.00
PROV cash_flow (annual, 2022-06-30) — Net Income From Continuing Operations: 9093000.00
PROV income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: 9093000.00
PROV income_statement (annual, 2022-06-30) — Net Interest Income: 31595000.00
PROV cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: 36823000.00
PROV cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -15983000.00
PROV cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -20983000.00
PROV cash_flow (annual, 2022-06-30) — Net Other Investing Changes: -84000.00
PROV balance_sheet (annual, 2022-06-30) — Net PPE: 8826000.00
PROV cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -165000.00
PROV cash_flow (annual, 2022-06-30) — Net Short Term Debt Issuance: 5000000.00
PROV balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 128650000.00
PROV income_statement (annual, 2022-06-30) — Normalized Income: 9093000.00
PROV income_statement (annual, 2022-06-30) — Occupancy And Equipment: 4471000.00
PROV cash_flow (annual, 2022-06-30) — Operating Cash Flow: 11793000.00
PROV income_statement (annual, 2022-06-30) — Operating Revenue: 36311000.00
PROV balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 7285184.00
PROV balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 2000.00
PROV income_statement (annual, 2022-06-30) — Other Non Interest Expense: 3007000.00
PROV balance_sheet (annual, 2022-06-30) — Other Properties: 2136000.00
PROV balance_sheet (annual, 2022-06-30) — Other Short Term Investments: 2676000.00
PROV balance_sheet (annual, 2022-06-30) — Payables: 17884000.00
PROV balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 17884000.00
PROV balance_sheet (annual, 2022-06-30) — Preferred Stock: 0.00
PROV balance_sheet (annual, 2022-06-30) — Prepaid Assets: 15180000.00
PROV income_statement (annual, 2022-06-30) — Pretax Income: 12858000.00
PROV cash_flow (annual, 2022-06-30) — Proceeds From Stock Option Exercised: 0.00
PROV income_statement (annual, 2022-06-30) — Professional Expense And Contract Services Expense: 1419000.00
PROV cash_flow (annual, 2022-06-30) — Purchase Of Investment: -19120000.00
PROV cash_flow (annual, 2022-06-30) — Purchase Of PPE: -165000.00
PROV balance_sheet (annual, 2022-06-30) — Receivables: 2966000.00
PROV income_statement (annual, 2022-06-30) — Reconciled Depreciation: 4849000.00
PROV cash_flow (annual, 2022-06-30) — Repayment Of Debt: -20983000.00
PROV cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: -4305000.00
PROV balance_sheet (annual, 2022-06-30) — Retained Earnings: 202680000.00
PROV income_statement (annual, 2022-06-30) — Salaries And Wages: 15833000.00
PROV cash_flow (annual, 2022-06-30) — Sale Of Investment: 55943000.00
PROV income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 642000.00
PROV income_statement (annual, 2022-06-30) — Selling General And Administration: 17018000.00
PROV balance_sheet (annual, 2022-06-30) — Share Issued: 18229615.00
PROV cash_flow (annual, 2022-06-30) — Short Term Debt Issuance: 5000000.00
PROV cash_flow (annual, 2022-06-30) — Stock Based Compensation: 798000.00
PROV balance_sheet (annual, 2022-06-30) — Stockholders Equity: 128650000.00
PROV balance_sheet (annual, 2022-06-30) — Tangible Book Value: 128650000.00
PROV income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
PROV income_statement (annual, 2022-06-30) — Tax Provision: 3765000.00
PROV income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.29
PROV balance_sheet (annual, 2022-06-30) — Total Assets: 1187038000.00
PROV balance_sheet (annual, 2022-06-30) — Total Capitalization: 213650000.00
PROV balance_sheet (annual, 2022-06-30) — Total Debt: 85000000.00
PROV balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 128650000.00
PROV balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 1058388000.00
PROV balance_sheet (annual, 2022-06-30) — Treasury Shares Number: 10944431.00
PROV balance_sheet (annual, 2022-06-30) — Treasury Stock: 173041000.00
PROV income_statement (annual, 2023-06-30) — +Total Revenue: 41060000.00
PROV balance_sheet (annual, 2023-06-30) — Accounts Payable: 17681000.00
PROV balance_sheet (annual, 2023-06-30) — Accounts Receivable: 3711000.00
PROV balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -14617000.00
PROV balance_sheet (annual, 2023-06-30) — Additional Paid In Capital: 99505000.00
PROV income_statement (annual, 2023-06-30) — Basic Average Shares: 7143273.00
PROV income_statement (annual, 2023-06-30) — Basic EPS: 1.20
PROV cash_flow (annual, 2023-06-30) — Beginning Cash Position: 23414000.00
PROV balance_sheet (annual, 2023-06-30) — Buildings And Improvements: 10311000.00
PROV cash_flow (annual, 2023-06-30) — Capital Expenditure: -741000.00
PROV balance_sheet (annual, 2023-06-30) — Capital Stock: 183000.00
PROV balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 65849000.00
PROV balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Federal Funds Sold: 65849000.00
PROV cash_flow (annual, 2023-06-30) — Cash Dividends Paid: -3998000.00
PROV cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 136006000.00
PROV cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -109896000.00
PROV cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Operating Activities: 16325000.00
PROV cash_flow (annual, 2023-06-30) — Change In Account Payable: 121000.00
PROV cash_flow (annual, 2023-06-30) — Change In Payable: 121000.00
PROV cash_flow (annual, 2023-06-30) — Change In Payables And Accrued Expense: 121000.00
PROV cash_flow (annual, 2023-06-30) — Change In Prepaid Assets: 1634000.00
PROV cash_flow (annual, 2023-06-30) — Change In Working Capital: 1755000.00
PROV cash_flow (annual, 2023-06-30) — Changes In Cash: 42435000.00
PROV balance_sheet (annual, 2023-06-30) — Common Stock: 183000.00
PROV cash_flow (annual, 2023-06-30) — Common Stock Dividend Paid: -3998000.00
PROV balance_sheet (annual, 2023-06-30) — Common Stock Equity: 129687000.00
PROV cash_flow (annual, 2023-06-30) — Common Stock Payments: -4648000.00
PROV cash_flow (annual, 2023-06-30) — Deferred Income Tax: 1231000.00
PROV cash_flow (annual, 2023-06-30) — Deferred Tax: 1231000.00
PROV cash_flow (annual, 2023-06-30) — Depreciation Amortization Depletion: 3188000.00
PROV cash_flow (annual, 2023-06-30) — Depreciation And Amortization: 3188000.00
PROV income_statement (annual, 2023-06-30) — Diluted Average Shares: 7191685.00
PROV income_statement (annual, 2023-06-30) — Diluted EPS: 1.19
PROV income_statement (annual, 2023-06-30) — Diluted NI Availto Com Stockholders: 8592000.00
PROV cash_flow (annual, 2023-06-30) — End Cash Position: 65849000.00
PROV cash_flow (annual, 2023-06-30) — Financing Cash Flow: 136006000.00
PROV cash_flow (annual, 2023-06-30) — Free Cash Flow: 15584000.00
PROV balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: -38000.00
PROV income_statement (annual, 2023-06-30) — General And Administrative Expense: 18394000.00
PROV balance_sheet (annual, 2023-06-30) — Gross PPE: 23848000.00
PROV balance_sheet (annual, 2023-06-30) — Held To Maturity Securities: 154337000.00
PROV cash_flow (annual, 2023-06-30) — Income Tax Paid Supplemental Data: 2725000.00
PROV income_statement (annual, 2023-06-30) — Insurance And Claims: 657000.00
PROV income_statement (annual, 2023-06-30) — Interest Expense: 9007000.00
PROV income_statement (annual, 2023-06-30) — Interest Income: 45992000.00
PROV cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 7480000.00
PROV balance_sheet (annual, 2023-06-30) — Invested Capital: 364696000.00
PROV cash_flow (annual, 2023-06-30) — Investing Cash Flow: -109896000.00
PROV balance_sheet (annual, 2023-06-30) — Investments And Advances: 156492000.00
PROV cash_flow (annual, 2023-06-30) — Issuance Of Debt: 65000000.00
PROV balance_sheet (annual, 2023-06-30) — Land And Improvements: 2853000.00
PROV balance_sheet (annual, 2023-06-30) — Leases: 3135000.00
PROV balance_sheet (annual, 2023-06-30) — Long Term Debt: 235009000.00
PROV balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 235009000.00
PROV cash_flow (annual, 2023-06-30) — Long Term Debt Issuance: 65000000.00
PROV cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -30000000.00
PROV balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 5226000.00
PROV cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: -4648000.00
PROV balance_sheet (annual, 2023-06-30) — Net Debt: 169160000.00
PROV income_statement (annual, 2023-06-30) — Net Income: 8592000.00
PROV income_statement (annual, 2023-06-30) — Net Income Common Stockholders: 8592000.00
PROV income_statement (annual, 2023-06-30) — Net Income Continuous Operations: 8592000.00
PROV income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: 8592000.00
PROV income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: 8592000.00
PROV cash_flow (annual, 2023-06-30) — Net Income From Continuing Operations: 8592000.00
PROV income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: 8592000.00
PROV income_statement (annual, 2023-06-30) — Net Interest Income: 36985000.00
PROV cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: 31081000.00
PROV cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: 150009000.00
PROV cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: 35000000.00
PROV cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -424000.00
PROV cash_flow (annual, 2023-06-30) — Net Other Investing Changes: -1266000.00
PROV balance_sheet (annual, 2023-06-30) — Net PPE: 9231000.00
PROV cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -741000.00
PROV cash_flow (annual, 2023-06-30) — Net Short Term Debt Issuance: 115009000.00
PROV balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 129687000.00
PROV income_statement (annual, 2023-06-30) — Normalized Income: 8592000.00
PROV income_statement (annual, 2023-06-30) — Occupancy And Equipment: 4599000.00
PROV cash_flow (annual, 2023-06-30) — Operating Cash Flow: 16325000.00
PROV income_statement (annual, 2023-06-30) — Operating Revenue: 41060000.00
PROV balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 7043170.00
PROV balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: -38000.00
PROV income_statement (annual, 2023-06-30) — Other Non Interest Expense: 3138000.00
PROV balance_sheet (annual, 2023-06-30) — Other Properties: 2323000.00
PROV balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 2155000.00
PROV balance_sheet (annual, 2023-06-30) — Payables: 17681000.00
PROV balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 17681000.00
PROV balance_sheet (annual, 2023-06-30) — Preferred Stock: 0.00
PROV balance_sheet (annual, 2023-06-30) — Prepaid Assets: 10531000.00
PROV income_statement (annual, 2023-06-30) — Pretax Income: 12416000.00
PROV income_statement (annual, 2023-06-30) — Professional Expense And Contract Services Expense: 1517000.00
PROV cash_flow (annual, 2023-06-30) — Purchase Of Investment: 0.00
PROV cash_flow (annual, 2023-06-30) — Purchase Of PPE: -741000.00
PROV balance_sheet (annual, 2023-06-30) — Receivables: 3711000.00
PROV income_statement (annual, 2023-06-30) — Reconciled Depreciation: 3188000.00
PROV cash_flow (annual, 2023-06-30) — Repayment Of Debt: -30000000.00
PROV cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -4648000.00
PROV balance_sheet (annual, 2023-06-30) — Retained Earnings: 207274000.00
PROV income_statement (annual, 2023-06-30) — Salaries And Wages: 17737000.00
PROV cash_flow (annual, 2023-06-30) — Sale Of Investment: 31081000.00
PROV income_statement (annual, 2023-06-30) — Selling And Marketing Expense: 622000.00
PROV income_statement (annual, 2023-06-30) — Selling General And Administration: 19016000.00
PROV balance_sheet (annual, 2023-06-30) — Share Issued: 18229615.00
PROV cash_flow (annual, 2023-06-30) — Short Term Debt Issuance: 115009000.00
PROV cash_flow (annual, 2023-06-30) — Stock Based Compensation: 1185000.00
PROV balance_sheet (annual, 2023-06-30) — Stockholders Equity: 129687000.00
PROV balance_sheet (annual, 2023-06-30) — Tangible Book Value: 129687000.00
PROV income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
PROV income_statement (annual, 2023-06-30) — Tax Provision: 3824000.00
PROV income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.31
PROV balance_sheet (annual, 2023-06-30) — Total Assets: 1332948000.00
PROV balance_sheet (annual, 2023-06-30) — Total Capitalization: 364696000.00
PROV balance_sheet (annual, 2023-06-30) — Total Debt: 235009000.00
PROV balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 129687000.00
PROV balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 1203261000.00
PROV balance_sheet (annual, 2023-06-30) — Treasury Shares Number: 11186445.00
PROV balance_sheet (annual, 2023-06-30) — Treasury Stock: 177237000.00
PROV cash_flow (annual, 2023-06-30) — Unrealized Gain Loss On Investment Securities: 0.00
PROV income_statement (annual, 2024-06-30) — +Total Revenue: 38864000.00
PROV balance_sheet (annual, 2024-06-30) — Accounts Receivable: 4287000.00
PROV balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -14704000.00
PROV balance_sheet (annual, 2024-06-30) — Additional Paid In Capital: 98532000.00
PROV income_statement (annual, 2024-06-30) — Basic Average Shares: 6942918.00
PROV income_statement (annual, 2024-06-30) — Basic EPS: 1.06
PROV cash_flow (annual, 2024-06-30) — Beginning Cash Position: 65849000.00
PROV balance_sheet (annual, 2024-06-30) — Buildings And Improvements: 10136000.00
PROV cash_flow (annual, 2024-06-30) — Capital Expenditure: -1589000.00
PROV balance_sheet (annual, 2024-06-30) — Capital Stock: 183000.00
PROV balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 51376000.00
PROV balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Federal Funds Sold: 51376000.00
PROV cash_flow (annual, 2024-06-30) — Cash Dividends Paid: -3887000.00
PROV cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: -65220000.00
PROV cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: 45062000.00
PROV cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Operating Activities: 5685000.00
PROV cash_flow (annual, 2024-06-30) — Change In Account Payable: -2399000.00
PROV cash_flow (annual, 2024-06-30) — Change In Payable: -2399000.00
PROV cash_flow (annual, 2024-06-30) — Change In Payables And Accrued Expense: -2399000.00
PROV cash_flow (annual, 2024-06-30) — Change In Prepaid Assets: -2001000.00
PROV cash_flow (annual, 2024-06-30) — Change In Working Capital: -4400000.00
PROV cash_flow (annual, 2024-06-30) — Changes In Cash: -14473000.00
PROV balance_sheet (annual, 2024-06-30) — Common Stock: 183000.00
PROV cash_flow (annual, 2024-06-30) — Common Stock Dividend Paid: -3887000.00
PROV balance_sheet (annual, 2024-06-30) — Common Stock Equity: 129941000.00
PROV cash_flow (annual, 2024-06-30) — Common Stock Payments: -2601000.00
PROV cash_flow (annual, 2024-06-30) — Deferred Income Tax: -58000.00
PROV cash_flow (annual, 2024-06-30) — Deferred Tax: -58000.00
PROV cash_flow (annual, 2024-06-30) — Depreciation Amortization Depletion: 3155000.00
PROV cash_flow (annual, 2024-06-30) — Depreciation And Amortization: 3155000.00
PROV income_statement (annual, 2024-06-30) — Diluted Average Shares: 6959143.00
PROV income_statement (annual, 2024-06-30) — Diluted EPS: 1.06
PROV income_statement (annual, 2024-06-30) — Diluted NI Availto Com Stockholders: 7351000.00
PROV cash_flow (annual, 2024-06-30) — End Cash Position: 51376000.00
PROV cash_flow (annual, 2024-06-30) — Financing Cash Flow: -65220000.00
PROV cash_flow (annual, 2024-06-30) — Free Cash Flow: 4096000.00
PROV balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: -3000.00
PROV income_statement (annual, 2024-06-30) — General And Administrative Expense: 18422000.00
PROV balance_sheet (annual, 2024-06-30) — Gross PPE: 24017000.00
PROV balance_sheet (annual, 2024-06-30) — Held To Maturity Securities: 130051000.00
PROV cash_flow (annual, 2024-06-30) — Income Tax Paid Supplemental Data: 3090000.00
PROV income_statement (annual, 2024-06-30) — Insurance And Claims: 780000.00
PROV income_statement (annual, 2024-06-30) — Interest Expense: 19807000.00
PROV income_statement (annual, 2024-06-30) — Interest Income: 54730000.00
PROV cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 19762000.00
PROV balance_sheet (annual, 2024-06-30) — Invested Capital: 368441000.00
PROV cash_flow (annual, 2024-06-30) — Investing Cash Flow: 45062000.00
PROV balance_sheet (annual, 2024-06-30) — Investments And Advances: 131900000.00
PROV cash_flow (annual, 2024-06-30) — Issuance Of Debt: 85500000.00
PROV balance_sheet (annual, 2024-06-30) — Land And Improvements: 2853000.00
PROV balance_sheet (annual, 2024-06-30) — Leases: 4065000.00
PROV balance_sheet (annual, 2024-06-30) — Long Term Debt: 238500000.00
PROV balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 238500000.00
PROV cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 85500000.00
PROV cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -30009000.00
PROV balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 5458000.00
PROV cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: -2601000.00
PROV balance_sheet (annual, 2024-06-30) — Net Debt: 187124000.00
PROV income_statement (annual, 2024-06-30) — Net Income: 7351000.00
PROV income_statement (annual, 2024-06-30) — Net Income Common Stockholders: 7351000.00
PROV income_statement (annual, 2024-06-30) — Net Income Continuous Operations: 7351000.00
PROV income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: 7351000.00
PROV income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: 7351000.00
PROV cash_flow (annual, 2024-06-30) — Net Income From Continuing Operations: 7351000.00
PROV income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: 7351000.00
PROV income_statement (annual, 2024-06-30) — Net Interest Income: 34923000.00
PROV cash_flow (annual, 2024-06-30) — Net Investment Purchase And Sale: 24110000.00
PROV cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: 3491000.00
PROV cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: 55491000.00
PROV cash_flow (annual, 2024-06-30) — Net Other Investing Changes: -63000.00
PROV balance_sheet (annual, 2024-06-30) — Net PPE: 9313000.00
PROV cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -1589000.00
PROV cash_flow (annual, 2024-06-30) — Net Short Term Debt Issuance: -52000000.00
PROV balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 129941000.00
PROV income_statement (annual, 2024-06-30) — Normalized Income: 7351000.00
PROV income_statement (annual, 2024-06-30) — Occupancy And Equipment: 4895000.00
PROV cash_flow (annual, 2024-06-30) — Operating Cash Flow: 5685000.00
PROV income_statement (annual, 2024-06-30) — Operating Revenue: 38864000.00
PROV balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 6847821.00
PROV balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: -3000.00
PROV income_statement (annual, 2024-06-30) — Other Non Interest Expense: 2984000.00
PROV balance_sheet (annual, 2024-06-30) — Other Properties: 1505000.00
PROV balance_sheet (annual, 2024-06-30) — Other Short Term Investments: 1849000.00
PROV balance_sheet (annual, 2024-06-30) — Preferred Stock: 0.00
PROV income_statement (annual, 2024-06-30) — Pretax Income: 10387000.00
PROV income_statement (annual, 2024-06-30) — Professional Expense And Contract Services Expense: 1530000.00
PROV cash_flow (annual, 2024-06-30) — Purchase Of Investment: 0.00
PROV cash_flow (annual, 2024-06-30) — Purchase Of PPE: -1589000.00
PROV balance_sheet (annual, 2024-06-30) — Receivables: 4287000.00
PROV income_statement (annual, 2024-06-30) — Reconciled Depreciation: 3155000.00
PROV cash_flow (annual, 2024-06-30) — Repayment Of Debt: -82009000.00
PROV cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -2601000.00
PROV balance_sheet (annual, 2024-06-30) — Retained Earnings: 209914000.00
PROV income_statement (annual, 2024-06-30) — Salaries And Wages: 17642000.00
PROV cash_flow (annual, 2024-06-30) — Sale Of Investment: 24110000.00
PROV income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 709000.00
PROV income_statement (annual, 2024-06-30) — Selling General And Administration: 19131000.00
PROV balance_sheet (annual, 2024-06-30) — Share Issued: 18229615.00
PROV cash_flow (annual, 2024-06-30) — Short Term Debt Payments: -52000000.00
PROV cash_flow (annual, 2024-06-30) — Stock Based Compensation: 240000.00
PROV balance_sheet (annual, 2024-06-30) — Stockholders Equity: 129941000.00
PROV balance_sheet (annual, 2024-06-30) — Tangible Book Value: 129941000.00
PROV income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
PROV income_statement (annual, 2024-06-30) — Tax Provision: 3036000.00
PROV income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.29
PROV balance_sheet (annual, 2024-06-30) — Total Assets: 1272200000.00